PPAR

PPAR

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptor superfamily ligand-activated transcription factors that include the following three subtypes: PPAR, PPAR, and PPAR/. Higher organisms' cellular differentiation, development, metabolism (carbohydrate, lipid, and protein), as well as tumorigenesis, are all crucially regulated by PPARs. All PPARs bind to particular regions of the target genes' DNA through heterodimerization with the retinoid X receptor (RXR). Triglyceride levels are reduced and energy homeostasis is regulated when PPAR- is activated. PPAR- activation improves the metabolism of glucose, whereas PPAR-/ activation improves the metabolism of fatty acids.

PPAR related products

Structure Cat No. Product Name CAS No. Product Description
V51357 (S)-Coriolic acid (13(S)-HODE) 29623-28-7 (S)-Coriolic acid (13(S)-HODE) is the endogenous ligand that activates PPARγ and is produced when linoleic acid is metabolized by 15-lipoxygenase (15-LOX).
V51337 10-Nitrolinoleic acid 774603-04-2 10-Nitrolinoleic acid is a novel agonist for the peroxisome proliferator-activated receptor γ (PPARγ).
V51360 13-Oxo-9E,11E-octadecadienoic acid 29623-29-8 13-Oxo-9E,11E-octadecadienoic acida an isomer of 9-oxo-ODA, is a novel and selective PPARα activator derived from tomato juice.
V52518 23-epi-26-Deoxyactein (27-Deoxyactein) 501938-01-8 23-epi-26-Deoxyactein is a natural, orally biologically active compound with anti-obesity and anti-tumor effects.
V10743 Aleglitazar 475479-34-6 Aleglitazar (RG-1439; RO-0728804;RG1439; RO0728804) is a novel and potent agonist of peroxisome proliferator-activated receptor (PPARα and PPARγ) with potential antidiabetic effects.
V11620 AMG-131 315224-26-1 AMG-131, also known as(INT-131) is a novel and potent hypoglycemic agent.
V29738 Angeloylgomisin H 66056-22-2 Angeloylgomisin H is a novel and potent lignin extract
V54368 Anti-NASH agent 1 2409685-41-0 Anti-NASH agent 1 (compound 3d) is an analogue of Elafibranor, a potent PPAR-α/δ agonist targeting non-alcoholic steatohepatitis (NASH).
V3310 Arhalofenate 24136-23-0 Arhalofenate (formerly known as JNJ-39659100 and/or MBX102) is a novel, selective, partial agonist of PPAR-γ (peroxisome proliferator-activated receptor).
V42051 AZD-9574 2756333-39-6 AZD-9574 is a potent, BBB (blood-brain barrier) permeable/penetrable PARP1 inhibitor that displays >8000-fold selectivity for PARP1 compared to PARP2/3/5a/6.
V3436 Balaglitazone 199113-98-9 Balaglitazone (also known as NNC-610645; NNC-612344; NN-2344; DRF-2593) is a selective partial agonist of PPARγ (peroxisome proliferator-activated receptor) with an EC50 of 1.351 μM for human PPARγ.
V50944 BAY-0069 420826-65-9 BAY-0069 is a novel PPARγ inverse agonist, and its IC50 values for human and mouse PPARγ are 6.3 nM and 24 nM, respectively.
V50945 BAY-4931 423150-91-8 BAY-4931 is a potent, covalent, selective PPARγ inverse agonist with IC50 of 0.17 nM.
V51342 BAY-4931 423150-91-8 BAY-4931 is a potent, covalent, selective PPARγ inverse agonist with IC50 of 0.17 nM.
V51330 Bezafibrate-d6 1219802-74-0 Bezafibrate-d6 is the deuterium labeled Bezafibrate.
V3800 BMS-711939 1000998-62-8 BMS-711939, an analog of BMS-687453, is a novel potent and selective peroxisome proliferator activated receptor (PPAR) alpha agonist, with an EC50 and IC50 of 4 nM for human PPARα and >1000-fold selectivity vs human PPARγ (EC50 of 4.5 μM) and PPARδ (EC50 > 100 μM) in PPAR-GAL4 transactivation assays.
V51348 Bocidelpar (ASP-0367; MA-0211) 2095128-20-2 Bocidelpar is a peroxisome proliferator-activated receptor delta (PPAR-δ) modulator.
V51347 Caulophyllogenin 52936-64-8 Caulophyllogenin is a novel and potent triterpene saponin extracted from M. polimorpha.
V51340 CAY-10410 596104-94-8 CAY10410 (11-Oxo-prosta-5Z), a 15d-PGJ2 analog, is a novel agonist of PPARγ.
V4093 Choline Fenofibrate 856676-23-8 Choline fenofibrate (formerly also known as ABT-335 or choline salt of fenofibric acid) is a novel, synthetic phenoxy-isobutyric acid derivate with antihyperlipidemic activity that acts as anPPARαagonist.
Contact Us Back to top